Jazz Pharmaceuticals plc
JAZZNASDAQHealthcare● Active
$232.04
$-6.53(-2.74%)
Market Cap$14.6B
P/E Ratio—
52W High$243.32
52W Low$105
Jazz Pharmaceuticals plc（JAZZ）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · JAZZ · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.36B) | $0.56B | $0.41B | ($0.22B) | ($0.33B) |
| Depreciation & Amort. | $0.70B | $0.66B | $0.64B | $0.63B | $0.55B |
| Stock-Based Comp. | $0.29B | $0.25B | $0.23B | $0.22B | $0.19B |
| Change in Working Capital | $0.02B | ($0.08B) | ($0.20B) | $0.01B | ($0.05B) |
| Net Cash from Operations | $1.36B | $1.40B | $1.09B | $1.27B | $0.78B |
| Investing Activities | |||||
| Capital Expenditure | ($0.06B) | ($0.05B) | ($0.02B) | ($0.50B) | ($0.05B) |
| Purchases of Investments | $0.00B | ($1.31B) | ($0.39B) | ($0.06B) | ($0.03B) |
| Sales of Investments | $1.36B | $0.84B | $0.27B | $0.06B | $1.09B |
| Net Cash from Investing | ($1.51B) | ($0.51B) | ($0.16B) | ($0.45B) | ($5.21B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.13B) | ($0.31B) | ($0.27B) | ($0.00B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.78B) | $0.37B | ($0.03B) | ($0.58B) | $3.87B |
| Net Cash from Financing | ($0.87B) | $0.02B | ($0.31B) | ($0.53B) | $3.97B |
| Free Cash Flow | |||||
| Free Cash Flow | $1.30B | $1.35B | $1.07B | $0.77B | $0.73B |
| FCF Margin %(computed) | 30.39% | 33.12% | 27.86% | 21.15% | 23.69% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Jazz Pharmaceuticals plc
关于Jazz Pharmaceuticals plc（JAZZ）现金流量表
Jazz Pharmaceuticals plc 2025财年经营活动现金流$1.36B，自由现金流$1.30B（FCF利润率30.39%），资本支出($0.06B)。
常见问题
JAZZ · 4 问Jazz Pharmaceuticals plc 2025财年自由现金流$1.30B，同比down3.8%。
JAZZ free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10